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Penicillium chrysogenum (renamed P. rubens) is the most studied member of a family
of more than 350 Penicillium species that constitute the genus. Since the discovery
of penicillin by Alexander Fleming, this filamentous fungus is used as a commercial
β-lactam antibiotic producer. For several decades, P. chrysogenum was subjected to
a classical strain improvement (CSI) program to increase penicillin titers. This resulted
in a massive increase in the penicillin production capacity, paralleled by the silencing of
several other biosynthetic gene clusters (BGCs), causing a reduction in the production
of a broad range of BGC encoded natural products (NPs). Several approaches have
been used to restore the ability of the penicillin production strains to synthetize the NPs
lost during the CSI. Here, we summarize various re-activation mechanisms of BGCs,
and how interference with regulation can be used as a strategy to activate or silence
BGCs in filamentous fungi. To further emphasize the versatility of P. chrysogenum as a
fungal production platform for NPs with potential commercial value, protein engineering
of biosynthetic enzymes is discussed as a tool to develop de novo BGC pathways for
new NPs.
Keywords: Penicillium chrysogenum, natural products, nonribosomal peptides, polyketides, gene activation,
biosynthetic gene clusters, cell factory
INTRODUCTION
Since the discovery of penicillin by Alexander Fleming produced by the filamentous fungus
Penicillium notatum, the genus Penicillium has been deeply studied for its capacity to produce a
wide range of natural products (NPs) (secondary metabolites), many of them with biotechnological
and pharmaceutical applications. P. chrysogenum (recently renamed as P. rubens) is the most
relevant member of more than 354 Penicillium species that constitute the genus (Nielsen et al.,
2017). Penicillium is usually found in indoor environments and associated with food spoilage. It
is known as an industrial producer of β-lactam antibiotic in particularly penicillin, and current
production strains result from several decades of classical strain improvement (CSI) (Gombert
et al., 2011; Houbraken et al., 2011). The CSI program began in 1943 with the isolation of
P. chrysogenum NRRL 1951 capable of growing in submerged cultures. This strain was subjected
to a long serial process of mutations induced by 275 nm ultraviolet and X-ray irradiation, nitrogen
mustard gas and nitroso-methyl guanidine exposure, single spore selection and selection for loss
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of pigments, improved growth in large scale industrial fermenters
and enhanced levels of penicillin production. CSI programs
were developed in several companies (Barreiro et al., 2012),
and this has resulted in an increase of penicillin titers by
at least three orders of magnitude (van den Berg, 2010). As
consequence, numerous genetic modifications were introduced
in P. chrysogenum. Some have been studied in detail, most
notably the amplification of the penicillin biosynthetic clusters
and DNA inversions in this region (Fierro et al., 1995, 2006;
Barreiro et al., 2012). Although the CSI had a major impact
on the production of β-lactams by P. chrysogenum, it also
affected secondary metabolism in general. Indeed, a proteome
analysis performed between P. chrysogenum NRRL 1951 and
two derived strains (Wisconsin 54-1255 and AS-P-78) showed
reduced levels of proteins related to secondary metabolism in the
higher penicillin producer strains (Jami et al., 2010). Genome
sequencing of P. chrysogenum Wisconsin 54-1255 revealed the
presence of several secondary metabolite encoding biosynthetic
gene clusters (BGCs) in addition to the penicillin cluster, most of
which have only be poorly studied and remain to be characterized
(Figure 1). The products of the BGCs are either nonribosomal
peptides (NRPs), polyketides (PKs) or hybrid molecules.
Penicillium chrysogenum produces a broad range of
secondary metabolites such as roquefortines, fungisporin (a
cyclic hydrophobic tetrapeptide), siderophores, penitric acid,
ω-hydroxyemodin, chrysogenin, chrysogine, sesquiterpene
PR-toxin and sorbicillinoids, but likely also possesses the ability
to produce other compounds not detected before. For most of the
identified compounds, the responsible BGCs are unknown. The
development of new bioinformatics tools (SMURF, AntiSMASH)
(Khaldi et al., 2010; Weber et al., 2015; Blin et al., 2017) and
the increase in the number of fungal genomes sequenced to
date has opened the possibility to discover new NPs with
novel properties (genome mining). The genes involved in the
biosynthesis, regulation and transport of secondary metabolites
tend to be arranged in the genome in clusters. Importantly, these
gene clusters include the core biosynthetic genes which either
encode polyketide synthases (PKSs), nonribosomal peptide
synthetases (NRPSs) or terpene synthases genes (Smanski et al.,
2016). Recently, a global analysis was performed on 24 genomes
of Penicillium species and this identified 1,317 putative BGCs
predominated by two classes based on PKS (467) and NRPS
(260) (Nielsen et al., 2017). In P. chrysogenum there are 33 core
genes in the secondary metabolism that encode 10 NRPS, 20
PKS, 2 hybrid NRPS–PKS, and 1 dimethyl-allyl-tryptophan
synthase (van den Berg et al., 2008; Khaldi et al., 2010; Medema
et al., 2011; Samol et al., 2016) (Figure 1). A large number of PKS
and NRPS enzymes are found also in other Penicillium species
but only part of these gene clusters are shared, which suggests
an unexplored potential of the secondary metabolome even in a
single genus.
Here, we summarize the most recent strategies for engineering
filamentous fungi with particular attention to P. chrysogenum,
a promising cell factory of novel products with new application
spectra. A brief description of the key biosynthetic enzymes
involved in biosynthesis of secondary metabolites in fungi is
provided.
THE BUILDING ENZYMES OF THE
NATURAL PRODUCTS
Nonribosomal peptide synthetases are large, highly structured
and complex enzymatic machineries, closely related to other
modular enzymes such as PKSs, NRPS–PKS hybrid synthetases
and fatty acid synthetases (FASs). They have certain distinct
properties in common, the most striking one being their
structural division in domains and modules, which is manifested
in their shared evolutionary history (Smith and Sherman,
2008). Every enzyme minimally consists of one module, a
functionally distinct unit, which allows for the recruitment and
subsequent incorporation of a precursor into a growing product.
Domains as well as modules are clearly defined and evolutionary
exchangeable structures amongst multi-modular enzymes. In the
case of PKS and NRPS, this led to the occurrence of a variety of
NRPS–PKS hybrids (Du and Shen, 2001; Shen et al., 2005; Li et al.,
2010; Nielsen et al., 2016).
Nonribosomal Peptides (NRPs) and
Nonribosomal Peptide Synthetases
(NRPSs)
In comparison to most ribosomally derived peptides, NRPs
are low molecular weight products. The structural diversity of
NRPs is tremendous, mostly due to their chemical complexity.
Significantly contributing to this diversity is the fact that NRPS
are not only reliant on proteinogenic amino acids, but up until
now more than 500 substrates were identified, which serve as
NRPS building blocks (Caboche et al., 2008). These molecules
are predominantly amino acids, but not exclusively, since fatty
acids, carboxylic acids and others substrates have been reported
in NRPs (Marahiel et al., 1997). NRP thus represent a diverse
group of natural compounds and occur as linear, branched,
circular or macrocircular structures (Dang and Sussmuth, 2017;
Sussmuth and Mainz, 2017). The natural functions of NRPs are as
diverse as their structures. Signaling, communication, metal-ion
chelation, host protection are important functions performed by
NRPs, though many compounds are not yet fully characterized
in this respect. Nevertheless, the characterization of NPs for
applied purposes is well developed and led to a vast collection
of ground-breaking pharmaceuticals, including antibiotics, anti-
fungal agents, immunosuppressants as well as cytostatic drugs
(Frisvad et al., 2004; Watanabe et al., 2009; Dang and Sussmuth,
2017).
Structurally, every NRPS module, initiation (1), elongation
(n) or termination (1), requires a minimal set of domains
(Figure 2A) (Stachelhaus and Marahiel, 1995). The two domains
essential to every module are the adenylation domain (A)
and the non-catalytic thiolation domain (T). This tandem
di-domain enables the specific selection and activation of a
given substrate. However, the T-domain must first go through
4′-phosphopantetheinyl transferase (PPTase) and coenzyme A
(CoA) dependent activation after expression, by transferring the
phosphopantetheine moiety of CoA onto a conserved serine
residue, in order to enter the holo state. Also, adenylation
domains (A) have accompanying factors, or proteins, called
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FIGURE 1 | Chromosomal localization of known and predicted PKS and NRPS genes and representative structures of associated secondary metabolites identified
in Penicillium chrysogenum. Chromosomal localization of PKS and NRPS genes. Blue and red lines indicate known and unknown associated products so far,
respectively.
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FIGURE 2 | (A) Nonribosomal peptide synthetases (NRPSs) and (B) polyketide synthase (PKS) minimal domain structure. For details see the text. C, condensation
domain; PCP, peptidyl carrier protein; A, adenylation domain; E, epimerase; MT, methyltransferase; PPT, 4’-phosphopantetheine transferase domain; Oxy,
oxygenation domain; Cy, cyclization domain; ACP, acyl carrier protein; AT, acyltransferase domain; KS, ketosynthase domain; KR, ketoreductase domain; DH,
dehydratase domain; ER, enoyl reductase domain; Te, thioesterase domain.
MbtH-like proteins (MLPs) (Quadri et al., 1998; Baltz, 2011).
In contrast to PPTases, MLPs are merely interacting with the
A-domain, however, they do not have an intrinsic enzymatic
activity, but rather a chaperoning function upon binding a
distinct part of the A domain (Felnagle et al., 2010; Miller
et al., 2016; Schomer and Thomas, 2017). In addition to these
domains, any elongation module will require a condensation
domain (C), which connects two modules and links up-
and downstream activated substrates via a peptide bond.
C-domains are stereospecific for both, up- and downstream
activated substrates and render the resulting intermediate
compound attached to the downstream T-domain. Lastly, the
C-terminal termination module essentially requires a thioesterase
domain (Te), to catalytically release the covalently bound
compound of the NRPS, returning the NRPS complex to the
ground state for another reaction cycle. In addition to these
essential domains, we can distinguish a series of additional
domains, performing epimerization, halogenation, cyclization,
macrocyclization, multimerization or methylation (Ansari et al.,
2008; Horsman et al., 2016; Bloudoff and Schmeing, 2017).
Theses enzymatic machineries can be classified as type I NRPS
when the modules are arranged on a single protein, while the
type II NRPS are independent proteins in an transient manner
during the NRP synthesis (Sattely et al., 2008; Hur et al., 2012).
A NRPS can be as simple as a single modular unit containing
three domains, although the most complex and largest structure
known contains 15 modules with 46 domains (Wang H. et al.,
2014; Bode et al., 2015) yielding a 1.8 MDa protein complex
(type I NRPS). Although the size of a NRPS, as well as the
modular sequence, limits the setup of the resulting NRP, it is
common that NRPS cluster and interact with tailoring enzymes
in order to produce products of a higher complexity (Yin and
Zabriskie, 2006). To enable such specific interactions, NRPS
can contain small stretches of up to 30 amino acids at the C-
or N-terminus, which form a rather specific recognition point,
thus enabling communication (COM-domain) between multiple
NRPS of one cluster (type II NRPS) (Hahn and Stachelhaus, 2006;
Dowling et al., 2016). To date three types of NRPS system have
been described according to their synthesis mode (or strategy
of biosynthesis): Type A (linear), type B (iterative) and type C
(non-linear) (Figure 3). The type A system harbors the typical
domain organization A-T(C-A-T)n−1-Te/C, where n represents
the number of amino acids in the peptide. In this linear NRPS,
the order and number of modules correlates with the amino
acid sequence in the NRP and thus it is possible to predict
the product that will be formed. Usually, in fungal NRPSs the
cyclisation reaction is performed by a specialized C domain
instead of Te domain. Since each module catalyzes one cycle
during the chain elongation of the nascent NRP due to its
specific activity, this system is considered analogous to type I
PKS. In fungi, the most prominent examples of this type of
NRPS are ACV synthetases (β-lactams), cyclosporin synthetases
(Cyclosporin A) and peptaibol synthetases (peptaboils, a class
of antibiotics with a high content of α-aminoisobutyric acid)
(Wiest et al., 2002; Tang et al., 2007; Felnagle et al., 2008; Eisfeld,
2009). The type B system is characterized to employ all their
modules or domains more than once during the synthesis of a
single NRP, which enables the assembling of peptide chains that
contain repeated sequences along the structure (Mootz et al.,
2002). An example of this mode of synthesis occurs in Fusarium
scirpi during the biosynthesis of enniatin (antibiotic), which
is achieved through the repeated use of two modules. Other
examples of type B NRPSs are the siderophore synthetases, which
only contain three A domains that catalyze the biosynthesis of
ferrichrome (Mootz et al., 2002; Eisfeld, 2009). In type C system,
the non-linear NRPSs have at least one domain conformation
that deviate from (C-A-T)n−1 organization contained in linear
NRPSs. Likewise, in these synthetases the module arrangement
does not correspond to the amino acid sequence in the NRP.
Unlike type A NRPS, in type C NRPSs the non-linear peptide is
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FIGURE 3 | Mode of biosynthesis of nonribosomal peptide synthetases. For details see the text. C, condensation domain; PCP, peptidyl carrier protein; A,
adenylation domain; E, epimerase; MT, methyltransferase; Te, thioesterase domain; Cy, cyclization domain.
produced by a branch-point synthase and contains uncommon
cyclization patterns. Another important difference is that non-
linear NRPSs can incorporate small soluble structures, such as
amines into the rising NRP through specialized C domains (Tang
et al., 2007; Felnagle et al., 2008; Hur et al., 2012). Capreomycin,
bleomycin and vibriobactin are examples of NRPs produced by
this type of synthetases (Felnagle et al., 2008). In continuation,
a brief description of the main NRPS domains features is
provided.
Adenylation (A) and Thiolation (T) Domains
Any NRPS module minimally consists of an A- and T-domain
(or peptidyl carrier protein, PCP), enabling single module
functionality and multi-modular functionality upon addition
of C domains (Linne and Marahiel, 2000; Bergendahl et al.,
2002; Felnagle et al., 2008; Kittilä et al., 2016; Bloudoff and
Schmeing, 2017). They are often referred to as “gatekeeper”
domains, as there is no subsequent product formation without
prior adenylation and thioesterification of a substrate (Sun
et al., 2014). The two core functions of the A-domain are
characterized first, through the hydrolysis of ATP or adenylation,
allowing an AMP-substrate conjugate to be formed, which
is subsequently transferred to the free thiol group of the
4′-phosphopantetheinyl-moiety (Ppant), which is anchored to
a conserved serine residue in the downstream T-domain
(Ku et al., 1997; Weber and Marahiel, 2001; Neville et al.,
2005).
Condensation Domains (C)
C-domains are approximately 450 residue NRPS domains,
representing a highly versatile class of NRPS domains.
Any NRPS composed of more than one module must
consequently contain at least one C-domain. However, also
single modular NRPS may contain C-domains, especially if
they cooperate with other NRPS. Essentially, the primary
target of a C-domain is the condensation of the up- and
downstream activated substrates through a nucleophilic attack,
mainly leading to the formation of an n-peptide linked via a
peptide bond. Nonetheless, several residues of the C-domain
may have the intrinsic potential to fulfill multiple functions
(Balibar et al., 2005; Teruya et al., 2012; Haslinger et al.,
2015).
Epimerization Domains (E)
The E-domains are among the most abundant modification
domains intrinsic to NRPS. In contrast to the structurally similar
C domains they are responsible for the site specific epimerization
of a substrate, predominantly performing this function after
peptide bond formation has occurred (Bloudoff and Schmeing,
2017).
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Thioesterase Domains (Te)
The thiotemplate based enzymatic systems rely on a catalytic
activity in order to remove a product or product-scaffold of
the primary enzyme. Therefore, most NRPS contain a domain
on their C-terminus responsible for precisely this purpose, the
thioesterase domain (Te). Te-domains are a common commodity
in single and multi-modular NRPS, although, in multi-NRPS
systems only the terminal NRPS contains this domain (Horsman
et al., 2016). Additionally, this domain harbors a quality control
activity (proofreading) to verify the correct configuration of the
nascent peptide (Martín and Liras, 2017).
Intrinsic Product Modifying Domains
In addition to the C-domain related epimerization domain,
discussed previously, there are cyclization (Cy), oxygenation
(Oxy) as well as methyl-transferase (MT). These domains have
been characterized to the extent of classifying their functions,
although, especially Cy- and Oxy-domains may occur as a
singular bi-functional unit or in a serial manner, respectively
(Walsh, 2016). Cy- and Oxy-domains, specifically replace the
classic function of C-domains, omitting amino acid condensation
through peptide bond formation, resulting in thiazoline,
oxazoline or methyloxazoline structures (Sundaram and
Hertweck, 2016; Walsh, 2016). Those reactions predominantly
occur in siderophore producing NRPS and rely on the presence
of serine, threonine and cysteine residues (Patel et al., 2003;
Kelly et al., 2005). Also MT-domains follow the common
di-sub-domain structural patterning, which is also seen in A-,
C-, E-, and Cy-domains. Fundamentally, MT-domains, however,
are more restricted in their function, which covers the transfer
of methyl-groups from S-adenosylmethionine to N (N-MT),
C (C-MT), O (O-MT) or for certain residues S (S-MT) atoms
resolving around the amino acids Cα carbon (Miller et al.,
2003) and in case of S-MT Cβ, respectively (Al-Mestarihi et al.,
2014).
In P. chrysogenum 10 NRPS have been identified (Table 1) (van
den Berg et al., 2008; Medema et al., 2011; Samol et al., 2016),
of which only two have no attributed function. In this fungus,
next to fungisporin (Figure 1) which is a cyclic hydrophobic
tetrapeptide generated by a singular NRPS, three biosynthetic
pathways involving a NRPS have been described in detail:
penicillins, roquefortine/meleagrin, fungisporin and chrysogine
(Figure 4).
Polyketides and Polyketide Synthase
Polyketides were already discovered in 1883 by James Collie,
but the interest in these compounds (enzymes) was revived
only as late as the 1950s by the work of Arthur Birch on the
aromatic polyketide-6-methyl salicylic acid from P. patulum.
These molecules are a class of NPs, that display different types
of biological activities such as antibiotic (erythromycin A),
antifungal (amphotericin B), immunosuppressant (rapamycin),
antitumor (geldanmycin) and hypolipidemic (lovastatin) (Nair
et al., 2012; Jenner, 2016; Weissman, 2016). Their assembly
process is similar to that in the fatty acid biosynthesis, the
main difference is the optional full reduction of the β-carbon in
the PK biosynthesis. The group of enzymes that catalyzes the
biosynthesis of PKs is referred to as PKSs (Keller et al., 2005;
Caffrey, 2012).
In addition to the NRPSs, PKSs are the main enzymes
that build the structural scaffold of a wide range of secondary
metabolites and NPs in plants, bacteria, insects and fungi
(Brakhage, 2012; Nair et al., 2012). Usually, these enzymes are
encoded by genes that are grouped into clusters, that also specify
genes encoding tailoring enzymes (oxygenases, oxidoreductases,
reductases, dehydrogenases,and transferases), that further
modify the scaffold produced by the PKS into a final product
(Brakhage, 2012; Lim et al., 2012). PKSs are multimodular and
multidomain enzymes that use a specific acyl-coenzyme A (acyl-
CoA; usually malonyl-CoA or methylmalonyl-CoA) as building
block, and subsequently catalyze a decarboxylative Claisen-type
condensation of ketide units. The basic structural architecture
consists of an acyl carrier protein (ACP), a ketosynthase
(KS) and an acyltransferase (AT) domain. These combined
domains extent a linear intermediate by two carbon atoms.
An optional set of domains (dehydratase (DH), ketoreductase
(KR), enoyl reductase (ER) and thioesterase (TE) may provide
further modifications of the linear intermediate (Staunton and
Weissman, 2001; Brakhage, 2012; Nair et al., 2012; Dutta et al.,
2014).
According to their protein architecture and mode of
action, PKS enzymes are classified into types I, II, and III
(Figure 5). Type I PKSs are mainly found in bacteria and
fungi. These multidomain proteins can be further subdivided
in two categories: modular and iterative (Nair et al., 2012)
Modular type I PKSs or non-iterative PKSs are unique for
bacteria and are characterized by presenting a sequence (or
set) of modules, each constituted with a set of specific catalytic
domains. In consequence, the number of precursors fused
in the PK is equivalent to the number of modules which
are present (Chan et al., 2009). In contrast, iterative type
I PKSs use the same catalytic core domains as modular
type I PKSs, but the catalytic reaction is repeated to yield
the complete PK backbone. A representative example of this
type is LovB, that together with LovC (a enoyl reductase)
catalyzes around 35 reactions to produce dihydromonacolin
L, an intermediate in the lovastatin biosynthesis (Chan et al.,
2009; Campbell and Vederas, 2010). Like iterative type I
PKS enzymes, fungal PKSs (Figure 2B) are restricted to a
single module and the consecutive domains act in sequential
order during the synthesis of the complete PK. They are
equipped with basic structural domains typically found in
PKS enzymes (ACP-KS-AT domains) but may also contain
optional units (KR, DH, ER, and Te domains). Depending
on the presence or absence of reducing domains, these
enzymes can be divided into highly reducing (HR), non-
reducing (NR) and partially reducing (PR) PKS (Figure 2B)
(Keller et al., 2005; Crawford and Townsend, 2010; Jenner,
2016).
Highly Reducing PKS (HR-PKS)
Highly reducing PKS (HR-PKS) produce the linear or cyclic
scaffold of some compounds such as fumonisins, T-toxins,
solanapyrone E, squalestatin or/and lovastatin (Chiang et al.,
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FIGURE 4 | NRPS based biosynthetic pathways in P. chrysogenum.∗ Is not part of the biosynthetic gene cluster (BGC). Adapted from Harris et al. (2009),
Bartoszewska et al. (2011), García-Estrada et al. (2011), Weber et al. (2012c), Ali et al. (2013), Ozcengiz and Demain (2013), Ries et al. (2013), and Viggiano et al.
(2017).
2014; Roberts et al., 2017). Usually, they start with a KS domain,
followed by an AT, DH and C-Met domain, although the latter
does not always follow the DH domain. The ER domain is an
optional unit in HR-PKS enzymes, but when the ER is missing,
the corresponding region is filled with a polypeptide domain
with an unknown function. Furthermore, these enzymes do not
contain a product template domain (PT) or N-terminal SAT
domain, whereas these special domains are present in NR-PKS
enzymes (Cox and Simpson, 2010).
Partially Reducing PKS (PR-PKS)
Structurally, these enzymes have a domain architecture that
is similar to the mammalian FAS: a N-terminal KS-domain
followed by an AT-, DH-, and “core”-KR-ACP domain. These
TABLE 1 | Nonribosomal peptide synthetases (NRPSs) in P. chrysogenum and known associated products.
Gene ID Gene name Protein Domain organization Product/Pathway
Pc13g05250 pssC Siderophore synthetase A1TCA2TCTCA3TCTCT Siderophore
Pc13g14330 – Tetrapeptide synthetase CA1TECA2TCA3TCA3TCA4TC –
Pc16g03850 pssA∗ Siderophore synthetase ATCTA Coprogen
Pc16g04690 hcpA Cyclic tetrapeptide synthetase A1TECA2A3TCA4TECTCT Fungisporin
Pc21g01710 nrpsA Dipeptide synthetase A1TCA2T Brevianamide F
Pc21g10790 – Hexapeptide synthetase A1TCA2TCA3TECA4TCA5TCA6TC –
Pc21g12630 chyA 2-Aminobenzamide synthetase A1TCA2TC Chrysogine
Pc21g15480 roqA Histidyl-tryptophanyldiketo- piperazine synthetase A1TCA2TC Roquefortine/Meleagrin
Pc21g21390 pcbAB α-Aminoadipyl-cysteinyl-valine synthetase A1TCA2TCA3TEte β-lactams
Pc22g20400 pssB Siderophore synthetase ATCTC Fusarinines
A, adenylation; T, thiolation; E, epimerization; te, thioesterase; C, condensation. ∗Point mutations present in nrps genes of industrial P. chrysogenum strains subject to CSI
program. Modified from Salo et al. (2015), Samol et al. (2016), and Guzmán-Chávez et al. (2018).
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FIGURE 5 | Mode of biosynthesis of polyketide synthases. For details see the text. Abbreviations are as in the legend to Figure 2. Iterative type I PKS is depicted in
Figure 2B.
enzymes lack an ER domain (Wang L. et al., 2015), and also do
not have a Te domain, which suggests an alternative mechanism
of product release than hydrolysis. PR-PKS enzymes produce
small aromatic molecules such as 6-methylsalicylic acid (MSA),
but in most cases the chemical product is unknown (Cox and
Simpson, 2009, 2010; Kage et al., 2015).
Non-reducing PKS (NR-PKS; Aromatic PKs)
Non-reducing PKS (NR-PKS; aromatic PKs) typically, consist of
six catalytic domains that are covalently associated and arranged
in four components: loading (SAT), chain extension (KS-MAT-PT-
ACP), cyclisation and processing components (TE-CLC) (Bruegger
et al., 2013).
Type II PKSs are unique for bacteria and use a similar
iterative mechanism as observed in iterative type I PKSs. However,
the different catalytic domains are encoded by independent
genes. In general, they often constitute a “minimal PKS,”
which comprises of two KS units (KSα and KSβ) and an ACP
protein that holds the growing PKS chain. The KSβ domain
defines the length of the PK chain. The folding pattern of
the poly-β-keto intermediates is determined by optional PKS
units such as aromatases, ketoreductases, and cyclases. Other
tailoring modifications are performed by oxygenases, methyl
and glycosyl transferases. Known metabolites synthetized by
type II PKSs are tetracyclines, anthracyclines and aureolic acids
(Hertweck et al., 2007; Jenner, 2016). Type III PKSs have
originally been discovered in plants but are also present in
bacteria and fungi. They consist of a single KS domain that
catalyzes a defined number of elongations, usually generating
small phenols or naphtol rings. The enzyme transfers the acyl
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group from the CoA to the active site histidine, which is a
highly conserved residue. However, the amino acid sequence
of the his motif is not similar to those found in KS domains
of type I and II PKS enzymes (Shen, 2003; Chan et al., 2009;
Bruegger et al., 2014; Jenner, 2016). Importantly, independent
of the mechanistic or structural differences, all the PKs
synthetized by PKS enzymes follow the same decarboxylative
condensation mechanism of the acyl-CoA precursors. However,
these precursors should be activated in prior by the ACP domain,
in the case of the type I and II PKS enzymes, whereas type
III PKS enzymes act independently of ACP domains (Shen,
2003; Hopwood, 2009). Acridones, pyrenes as well as (and)
chalcones are some examples of the compounds produced
by type III PKS enzymes (Yu et al., 2012). Below, a brief
description is provided on the main catalytic features of PKS
domains.
Acyltransferase Domains (AT)
A main unit during PK biosynthesis is the AT domain that selects
the starter unit (malonyl-CoA or methylmalonyl-CoA) before it
is transferred to the ACP domain for the chain elongation cycle
(Dunn et al., 2013). This process involves two steps, i.e., the
acylation and the transfer to the ACP (Jenner, 2016).
Acyl Carrier Protein (ACP)
The ACP is an essential cofactor that participates in PK
biosynthesis. This protein belongs to a highly conserved carrier
family, and consists of 70–100 amino acid residues (Byers and
Gong, 2007). To perform the PK biosynthesis, the holo-ACP
(active) form is generated by the phosphopantetheinyl transferase
enzyme (PPTase) through a post-translational modification of
ACP whereby a 4′-phosphopantetheine (4′-PP) moiety from
CoA is transferred to the conserved serine (Evans et al., 2008;
Kapur et al., 2010; Jenner, 2016) resulting in the formation of
the Ppant arm. ACP modulates three important events during
PK biosynthesis. First, it allows the condensation during chain
elongations since it transfers the starter unit from the AT
domain to the KS domain. Second, it shuttles the growing chain
between the up and downstream domains, as well as to optional
PKS domains, probably involving protein–protein recognition
between domains. Third, it prevents premature cyclization and
enolization of the PK chain (Yadav et al., 2013).
Ketosynthase Domains (KS)
The KS is a homodimeric condensing domain that catalyzes the
extension of the β-ketoacyl intermediate by a decarboxylative
Claisen condensation. This domain contains two active sites
which are accessible to the ACP through its flexible Ppant arm,
which receives the β-carboxyacyl-CoA extender unit from the
AT. At that stage, a thioester bond is formed between the active-
site cysteines’ thiol group of the KS and the growing PK. Only
when both units are covalently attached onto the module, a
decarboxylative Claisen condensation occurs, which involves two
conserved his residues. Therefore, mechanistically the KS domain
acts at three stages: acylation, decarboxylation and condensation
(Chen et al., 2006; Caffrey, 2012; Yadav et al., 2013; Jenner, 2016;
Robbins et al., 2016).
Ketoreductase Domains (KR)
The KR domain functions as a β-carbon processing unit that
belongs to the family of short-chain dehydrogenase/reductases.
This domain reduces the β-keto group, that is formed during
the condensation process, into a hydroxyl group (a β-hydroxyl
intermediate) using NADPH (Keatinge-Clay and Stroud, 2006;
Caffrey, 2012). Additionally, some KR domains are equipped
with epimerase activity. The epimerizing module has a more
open architecture, enabling the catalytic epimerization of methyl
groups in acyl-ACP substrates, a reaction that involves the
conserved serine and tyrosine residues which are also employed
during ketoreduction (Ostrowski et al., 2016c; Bayly and Yadav,
2017).
Dehydratase Domains (DH)
The DH domain is usually coupled to B-type KR domains (B-
type). This domain catalyzes water elimination (via syn or anti) at
the β-hydroxy acyl chain position thereby producing trans double
bonds (α,β-unsaturated moieties) (Caffrey, 2012; Bruegger et al.,
2014; Jenner, 2016; Bayly and Yadav, 2017).
Enoyl Reductase Domains (ER)
The ER domain is an optional tailoring unit involved in the
final oxidation state of the growing PK. It reduces α,β-enoyl
groups and thereby generates saturated α–β bonds. This reaction
involves NAD(P)H as hydride donor in a Michael addition type of
mechanism. In the enoyl reduction, the products formed during
this reaction have a specific stereochemistry (3R,2R) or (3R,2S)
due to the β-carbon attack performed by the pro-4R hydride
of NADPH, contrasting the KR domain that utilizes the pro-4S
hydride (Chen et al., 2006; Bruegger et al., 2014).
Thioesterase Domain (Te)
Termination of PK biosynthesis involves the Te domain, which
produces macrolactones via intramolecular cyclization or linear
PKs by hydrolysis (Keatinge-Clay, 2012). In both events, an acyl-
Te intermediate is formed through the transfer of the PK chain
from the last ACP to the active serine on Te domain (Jenner,
2016).
Special Domains
In non-reducing PKS, the ACP transacylase (SAT) domain acts
as starter unit that loads the ACP whereupon chain extension
is mediated for KS and AT domain. During this process,
the malonyl-CoA:ACP transacylase (MAT) domain transfers
the extension units from malonyl-CoA to the ACP, while the
product template (PT) domain stabilizes the reactive poly-β-keto
intermediates. The processing component acts after the initial
assembly when the cyclized or PK intermediate is still attached
to the ACP. Final cyclization and release is catalyzed by the
Te/Claisen cyclase (CLC) domain (Cox and Simpson, 2010;
Crawford and Townsend, 2010; Bruegger et al., 2013; Chiang
et al., 2014).
In P. chrysogenum, 20 PKS genes have been identified (Table 2)
(van den Berg et al., 2008; Medema et al., 2011; Samol et al.,
2016), but for only six the products are known. To date,
in P. chrysogenum only four PK-related pathways have been
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FIGURE 6 | PKS-based biosynthetic pathways in P. chrysogenum. Sorbicillinoids: Despite the fact that this cluster is also present in industrial strains of
P. chrysogenum, they do not produce sorbicillinoids due to a point mutation in the ketosynthase domain of SorA. Yanuthones/Patulin: P. chrysogenum only contains
a full version of one cluster (yanuthone D BGC), while the second cluster (patulin BGC) is incomplete (Nielsen et al., 2017). The absence of the gene encoding for an
isoepoxidon dehydrogenase agrees with the fact that this fungi does not produce patulin (Samol et al., 2016). However, under laboratory conditions, yanuthone D is
also not detected in this fungus (Salo, 2016). DHN-Melanin: The genes are only partially clustered in the genome of P. chrysogenum. Andrastin A: P. chrysogenum
strains subjected to CSI are not able to produce andrastin A or related compound. Adapted from Staunton and Weissman (2001), Maskey et al. (2005), Cox (2007),
Wattanachaisaereekul et al. (2007), Du et al. (2009), Pihet et al. (2009), Crawford and Townsend (2010), Avramovicˇ (2011), Harned and Volp (2011), Gallo et al.
(2013), Heinekamp et al. (2013), Matsuda et al. (2013), Salo et al. (2015), Salo et al. (2016), Druzhinina et al. (2016), Meng et al. (2016), Salo (2016), Samol et al.
(2016), Guzmán-Chávez et al. (2017), Guzmán-Chávez et al. (2018), Nielsen et al. (2017), and Rojas-Aedo et al. (2017).
described in detail: sorbicillinoids, MSA-6/yanuthones, DHN-
melanin and andrastin A (Figure 6).
Terpenoids Biosynthesis
In addition to NRPs and PKs, terpenoids are another class of
NPs that are synthetized by filamentous fungi (Ascomycota)
although less abundant as compared to Basidiomycota (Schmidt-
Dannert, 2014). Fungal terpenoids or isoprenoids are structurally
diverse molecules derived from isoprene units (C5 carbon
skeleton): isopentenyl pyrophosphate (IPP) and dimethylallyl
pyrophosphate (DMAPP), which are synthetized in the
mevalonate pathway from acetyl-CoA (Chiang et al., 2014;
Soltani, 2016). The head-to-tail condensation of these C5 units is
catalyzed by isoprenyl diphosphate synthases (IDSs), producing
isoprenyl diphosphates with 10 (geranyl, GPP), 15 (farnesyl,
FPP), and 20 (geranylgeranyl, GGPP) carbons. Eventually, these
linear chains of different length are further modified by cyclases,
terpene synthases (TPs) and prenyl transferases (PTs), yielding
different subclasses of terpenoids (Schmidt-Dannert, 2014; Chen
et al., 2016). For instance, monoterpenoids, sesquiterpenoids,
diterpenoids, sesterterpenoids, and triterpenoids, which harbor
two to six isoprene units, respectively (Soltani, 2016). Terpenoids
are oxygenated derivatives of terpenes, which are also derived of
isoprene (Stashenko and Martinez, 2017).
In filamentous fungi such as Aspergillus, Penicillium,
Claviceps, and Neosartorya, ABBA-type PTs are involved in the
biosynthesis of a range of toxins (Schmidt-Dannert, 2014). For
the synthesis of indole-diterpenoids, IPPS-type PTs transfer
GGPP to a indole group, while UbiA-type PTs are involved
in the biosynthesis of meroterpenoids, which are hybrid NPs
(terpenoids and PKs) (Itoh et al., 2010; Schmidt-Dannert, 2014).
In A. nidulans, AusN (UbiA-type TPs) converts the product of
a NR-PKS (3,5-dimethylorsellinic acid) as part of an earlier step
in the dehydroaustinol/austinol biosynthesis pathway (Lo et al.,
2012).
Terpene synthases catalyze cyclization reactions forming
the carbocation by substrate ionization (class I) or substrate
protonation (class II) (Zhou et al., 2012; Meguro et al., 2014).
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A relevant example of class I TPs are sesquiterpene synthases,
which cyclize the FPP to obtain a sesquiterpene scaffold (C15
backbone) (Quin et al., 2014). Recently, the prx1 to prx4 gene
cluster involved in the biosynthesis of PR-toxin in P. roqueforti
was cloned and sequenced. This cluster contains the gene prx2
(ari1) that encodes for a aristolochene synthase which forms a
sesquiterpene aristolochene derivative (precursor of PR-toxin).
Interestingly, an orthologous gene cluster was identified in
P. chrysogenum (Pc12g06300 to Pc12g06330), as part of BGC
of eleven genes, which is also involved in the biosynthesis of
PR-toxin (Hidalgo et al., 2014).
STRATEGIES FOR ACTIVATION OF BGCS
Natural products represent a broad range of molecules produced
by animals, plants and microorganisms. These molecules may
display different biological activities (e.g., antiviral, antimicrobial,
anti-tumor, immunosuppressive agents) and it is estimated that
the majority of these compounds are derived from filamentous
fungal sources and from filamentous bacteria belonging to
the genus Streptomyces. With respect to antibiotics, most of
the chemical scaffolds used today were discovered during
the golden age of antibiotics discovery (1940–1960s). This
was followed by four decades during which hardly any new
scaffolds from a natural source were developed (Reen et al.,
2015; Smanski et al., 2016; Okada and Seyedsayamdost, 2017).
However, there is also a current understanding that only a
small fraction of the potential possible molecules has been
discovered to this date. This follows from genomic studies
revealing large numbers of uncharacterized BGCs, while many
of these gene clusters are not expressed (silent or sleeping
gene clusters) under laboratory conditions (Brakhage and
Schroeckh, 2011). Furthermore, metagenomics studies indicate
that the majority of microbes present in the environment have
not been cultured nor characterized. Thus, there are many
challenges that need to be overcome in order to harness
the natural diversity of NPs, to cultivate potential strains
under laboratory conditions and to activate the BGCs for
expression. To achieve the synthesis of new NPs, three main
approaches (Figure 7) were used in recent years, which may
be successfully applied in P. chrysogenum: manipulation of
cultivation conditions, engineering of NRPS and PKS and genetic
interference.
Manipulation of Cultivation Conditions
Under natural conditions, fungi face a variety of biotic and abiotic
conditions to survive. The cellular response to the environment
involves complex regulatory networks that respond to stimuli
such as light, pH, availability of carbon and nitrogen sources,
reactive oxygen species, thermal stress, and interspecies-crosstalk
(Brakhage, 2012; Reen et al., 2015).
OSMAC (One Strain Many Compounds) Approach
This strategy is derived from the observation that changes
in the metabolic output of microorganisms can be achieved
by alternating the medium composition and other cultivation
parameters. It is well known that glucose, ammonium, or
TABLE 2 | Polyketide synthases in P. chrysogenum and (insofar known) their associated products.
Gene ID Gene name Protein Domain organization Product/Pathway
Pc12g05590 pks1 – ks-at-dh-mt-kr-acp –
Pc13g04470 pks2∗ – ks-at-dh-mt-er-kr-acp –
Pc13g08690 pks3 – ks-at-dh-mt-er-kr-acp –
Pc16g00370 yanA 6-MSA synthase ks-at-kr-acp 6-MSA/Yanuthones
Pc16g03800 pks5 – ks-at-dh-er-kr-acp –
Pc16g04890 pks6 – ks-at-dh-mt-er-kr-acp –
Pc16g11480 pks7∗ – ks-at-dh-mt-er-kr-acp –
Pc21g00960 pks8∗ – ks-at-dh-mt-er-kr-acp –
Pc21g03930 pks9 – ks-at-dh-mt-er-kr-acp –
Pc21g03990 pks10 – ks-at-dh-er-kr-acp –
Pc21g04840 pks11 – ks-at-dh-er-kr-acp –
Pc21g05070 sorB∗ Sorbicillin synthase ks-at-acp-mt-te/red Sorbicillinoids
Pc21g05080 sorA∗ Sorbicillin synthase ks-at-dh-mt-er-kr-acp Sorbicillinoids
Pc21g12440 pks14 – ks-at-dh-er-kr-acp –
Pc21g12450 pks15∗ – ks-at-acp-te –
Pc21g15160 pks16 – ks-at-dh-mt-er-kr-acp –
Pc21g16000 alb1∗ YWA1 synthase ks-at-acp-acp-te YWA1/DHN-Melanin
Pc22g08170 patK 6-MSA synthase ks-at-kr-acp 6-MSA
Pc22g22850 adrD DMOA synthase ks-at-acp-mt-te/red DMOA/Andrastin A
Pc22g23750 pks20 – ks-at-dh-mt-er-kr-acp –
ks, ketosynthase; at, acyltransferase; dh, dehydratase; mt, methyltransferase; er, enoyl reductase; kr, ketoreductase; acp, acyl carrier protein; te/red, thioester reductase.
∗Point mutations present in pks genes of industrial P. chrysogenum strains subject to CSI program. Modified from Salo et al. (2015), Samol et al. (2016), and Guzmán-
Chávez et al. (2018).
Frontiers in Microbiology | www.frontiersin.org 11 November 2018 | Volume 9 | Article 2768
fmicb-09-02768 November 13, 2018 Time: 17:47 # 12
Guzmán-Chávez et al. Penicillium chrysogenum Cell Factory
phosphate at high concentrations act as repressors of secondary
metabolism, whereas iron starvation and nitrogen limitation
can stimulate secondary metabolite production. The latter is for
instance exploited for the production of terrain by A. terreus
(Bode et al., 2002; Brakhage and Schroeckh, 2011; Gressler et al.,
2015). This strategy can readily be implemented using high-
throughput methods, where an array of culture conditions can be
screened for new metabolite profiles (Spraker and Keller, 2014).
In combination with bioinformatics tools, this strategy can be
a powerful tool to investigate the production of new molecules,
as exemplified by the discovery of aspoquinolones A–D in
A. nidulans (Scherlach and Hertweck, 2006). However, despite
the fact that the OSMAC approach has led to the discovery of
increased numbers of new molecules with antimicrobial activity,
some chemical and physical conditions are still missing under the
laboratory tested conditions as the activation often concerns a
limited number of BGCs (Chiang et al., 2009).
Interspecies-Crosstalk
The production of secondary metabolites is a natural strategy
that microorganisms have developed to cope with specific
environmental conditions and challenges. They serve as
intermediary agents to establish a symbiotic association between
species or as a weapon against other organism to compete for
nutrients and space. These conditions, that are not present in
axenic cultures, boost the production of molecules that are
constitutively present and/or that are cryptic and normally
are not synthetized due to silencing of the respective BGCs
(Demain and Fang, 2000; Marmann et al., 2014). The strategy
in which different organisms are cultivated together is called
“co-culture,” which has been successful in several cases yielding
new metabolites. A. fumigatus produces fumiformamide when
co-cultivated with Streptomyces peucetius, while co-cultivation
of this fungi with S. rapamycinicus results in the production of
fumicyclines A and B, two novel PKs with antibacterial activity,
are examples of the use of this strategy (Netzker et al., 2015;
Adnani et al., 2017). Interestingly, the association of two marine
organisms, Emericella sp. and Salinispora arenicola, results in
the biosynthesis of emericellamides A and B which are equipped
with antibacterial activity (Oh et al., 2007). Also, the interactions
between fungi and insects result in the production of volatile
secondary metabolites (Rohlfs and Churchill, 2011).
Engineering of NRPS and PKS
Nonribosomal peptide synthetase and PKS are highly structured
and multi-facetted enzymes, containing a tremendous potential
for the exploitation of their product scaffold structure for the
generation of novel, bioactive compounds. However, due to
the complexity of all interactions within these mega enzymes,
the elucidation and implementation of engineering strategies
is an extremely challenging task. Several strategies have been
developed and applied with different degrees of success, though
the overall approaches can be grouped as module, domain,
sub-domain or site directed, respectively. Owing to their large
size, utilization of a random mutagenesis approach proved to
be difficult, but other more directed strategies are met with
a great success. Nevertheless, all of these strategies have their
inherent difficulties, advantages and disadvantages in respect to
the complexity and success rate of NRPS/PKS engineering efforts.
Subunit, Module, and Domain Swapping
Extensive efforts targeting the active site of A-domains has been
a major focus in NRPS engineering. Multiple studies confirmed
that the substrate specificity of a NRPS A-domain can be
successfully altered, however, at the cost of substantially lowered
catalytic velocity (Thirlway et al., 2012; Zhang et al., 2013).
Similar successes and limitations were observed when domains
were swapped or replaced by synthetic versions (Beer et al., 2014).
The most challenging way of obtaining novel NRPS, however,
is the swapping or combining of entire modules (Kries, 2016).
Domain swapping overall created not only functional parts or
domains, but also complete NRPS though with limited success
(Beer et al., 2014).
Due to the strict arrangement of NRPS in domains and
modules, the possibility of exchanging a unit appears to be
the most straight forward approach for altering its intrinsic
properties. A series of studies targeting the enzymes linked
to the production of daptomycin (Nguyen et al., 2006; Baltz,
2014) elucidated the possibilities and borders of a combinatorial
swapping strategy in context of novel compound production.
The daptomycin biosynthetic cluster comprises three NRPS
containing a total of 13 modules for the incorporation of
an equal number of substrates. Different levels of domain
and module swap approaches were followed, starting with
the exchange of modules 8 and 11 (C-A-T), representing an
internal module exchange. The resulting NRPS exhibited the
production of novel daptomycin compounds with an inverted
amino acid composition at the predicted sites at a near native
rate (Nguyen et al., 2006). A similar combinatorial approach
has been chosen for altering the PK stereochemistry. The
exchange of a R domain with a TE domain in a NR-PKS
from A. niger produced two alternative NR-PKS that harbor
carboxylic acids instead of the aldehydes present in the original
products (Yeh et al., 2013; Weissman, 2016). In Aspergillus,
this rational domain swap has also been used to diversify
the native substrates that NR-PKS takes as starter unit to
produce new products. This involved exchanging the starter
unit ACP transacylase domain in the PKS (Liu et al., 2014).
Likewise, an analogous approach was used to produce new
hybrids (PK–NRPs) in A. nidulans via module swapping of
the two PKS–NRPS natural hybrids involved in the syn2
and cytochalasin E pathways from Magnaporthe oryzae and
A. clavatus respectively (Nielsen et al., 2016). Despite the
successful use of this strategy in some filamentous fungi, the
engineering of NRPS and PKS in P. chrysogenum remains
unexplored.
Genetic Interference
Another mechanism to stimulate the expression of silent BGCs
in P. chrysogenum is by genetic interference, for instance by
direct manipulation of the regulatory network related to BGCs
expression. The regulation of BGCs is effected at many levels,
through specific (or local) and global regulators up to epigenetic
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regulation involving the modification of the chromatin landscape
(Lim et al., 2012; Spraker and Keller, 2014).
Global and Specific Regulators
Global regulator-based regulation
Pleiotropic transcriptional regulators or global regulators are
proteins that respond to environmental signals such as pH,
temperature, and N- and C-sources. They provide the link
between the production of secondary metabolites and external
cues. In fungi, these proteins control the regulation of BGCs
that do not contain other regulatory factors. Up to 40% of the
known clusters do not encode a local and specific regulator
(or obvious regulatory genes). Additionally, global regulators
also act on genes that do not belong to secondary metabolism
(Brakhage, 2012; Rutledge and Challis, 2015; Fischer et al., 2016).
Global regulators that have been reported as key players in the
biosynthesis of secondary metabolites are featured below.
Velvet complex. This heterotrimeric complex is a conserved
regulator present in most of the fungi, except yeast. It consists
of at least three proteins: VeA, VelB, and LaeA. Likewise,
this complex provides a link between sexual development and
secondary metabolism through light regulation (Yin and Keller,
2011; Deepika et al., 2016), since light has an inhibitory effect
on VeA expression. The formation of the velvet complex takes
place in the nucleus, where the complex VeA–VelB via the
α-importin KapA meets the methyltransferase LaeA. It has been
hypothesized that the velvet complex acts as a transcriptional
factor as it contains a DNA binding fold that resembles the
corresponding region of the NF-κB transcription factor of
mammals (Sarikaya-Bayram et al., 2015). The role of the velvet
complex in secondary metabolism mostly follows from the
control that the LaeA protein executes on several BGCs in
filamentous fungi. LaeA (loss of aflR expression-A) was identified
in 2004 as a global regulator in Aspergillus. Deletion of this
gene results in the repression of many BGC, such as the one
responsible for the production of penicillin, lovastatin, and
sterigmatocystin. Overexpression of LaeA causes an opposite
phenotype. Interestingly, LaeA is negatively regulated by AflR
(Zn2Cy6 transcriptional factor) in a feed loop mechanism (Bok
and Keller, 2004). It has been hypothesized that LaeA acts at
different levels, i.e., as a methyltransferase, epigenetically and
as a direct member of the velvex complex. Structurally, LaeA
has a S-adenosyl methionine (SAM)-binding site with a novel
S-methylmethionine auto-methylation activity, although this
activity does not seem to be essential for its function. LaeA is not a
DNA-binding protein, but it does affect chromatin modifications.
In an A. nidulans1laeA strain, high levels of the heterochromatin
protein 1 (HepA) are detected and an increase in trimethylation
of the H3K9 in the sterigmatocystin cluster. When LaeA is
present, the levels of HepA, ClrD (H3K9 methyltransferase)
and H3K9me3 decrease while the sterigmatocystin levels are
raised. The heterochromatic marks stay until the sterigmatocystin
cluster is activated, and apparently LaeA influences the offset
of these marks in this particular cluster (Reyes-Dominguez
et al., 2010; Brakhage, 2012; Jain and Keller, 2013; Sarikaya-
Bayram et al., 2015; Bok and Keller, 2016). Orthologs of LaeA
have been discovered in many other filamentous fungi as
Penicillium, Fusarium, Trichoderma, Monascus spp. and LaeA
exhibits positive and negative effects on the synthesis of NPs. For
instance, LaeA1 of F. fujikuroi positively regulates the production
of fusarin C, fumonisins and gibberellins, and represses bikaverin
biosynthesis. In P. chrysogenum, LaeA controls the biosynthesis
of penicillin, pigmentation and sporulation (Keller et al., 2005;
Kosalková et al., 2009; Jain and Keller, 2013). In Trichoderma
reesei, Lae1 positively modulates the expression of cellulases,
xylanases, β-glucosidases. Interestingly the stimulation of these
genes was not directly influenced by the methylation of H3K4
or H3K9 (Wiemann et al., 2010; Yin and Keller, 2011; Lim et al.,
2012; Seiboth et al., 2012; Jain and Keller, 2013).
LaeA is not the only member of the velvet complex that has
influence on the regulation of secondary metabolite production.
VeA of A. parasiticus is necessary for the expression of two
transcriptional factors of the aflatoxin cluster (AflR and AflJ),
which regulate the pathway. In A. fumigatus, veA regulates 12e
BGCs (Dhingra et al., 2013). This study also revealed that veA
modulates the biosynthesis of fumagillin via the regulation of
FumR, a transcriptional factor of the fumagillin cluster, which in
turn is also regulated by LaeA. Similarly, a transcriptome analysis
in A. flavus revealed that 28 of 56 BGCs are dependent on veA, in
particular the aflavarin cluster which is differentially expressed.
Likewise, orthologs of veA are also present in other fungi such as
in P. chrysogenum, F. oxysporum, Botrytis cinerea, F. verticillioides
(Yin and Keller, 2011; Dhingra et al., 2013; Jain and Keller, 2013;
Cary et al., 2015). Despite the clear interaction between veA
and LaeA in the velvet complex and its influence on secondary
metabolism, it is thought that veA may be acting as molecular
scaffold of the velvet complex, since it interacts also with three
other methyl transferases [LaeA-like methyltransferase F (LlmF),
velvet interacting protein C (VipC), and VipC associated protein
B (VapB)]. This suggests that veA functions in a supercomplex or
in dynamic network control. Taken together, modulation of the
velvet complex is a useful tool to activate BGCs (Sarikaya-Bayram
et al., 2015) but results are difficult to predict.
bZIP transcription factors. Basic leucine zipper (bZIP)
transcription factors are highly conserved in the eukaryotes.
The dimeric bZIP transcriptional factors play an important role
in the cellular responses to the environment. Regarding their
structure, they contain a conserved leucine zipper domain and
a basic region, which controls the dimerization of the protein
and establishes sequence-specific DNA-binding, respectively.
Once dimeric, bZIPs target palindromic DNA sequences by
two mechanisms: redox and phosphorylation (Amoutzias et al.,
2006; Knox and Keller, 2015). In fungi, bZIP proteins have
been implicated in multiple metabolic processes, such as in the
regulation of development, morphology and in stress responses.
Several orthologs of the Yap family bZIPs, which were first
described in yeast, have been characterized in Aspergillus spp.
(AtfA, NapA, Afyap1, Aoyap1, and Apyap1) and these regulators
have recently been associated with the production of secondary
metabolites in filamentous fungi. In A. nidulans, overexpression
of RsmA (restorer of the secondary metabolism A, Yap-like bZIP)
has a compensatory effect on secondary metabolism in a strain in
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which LaeA and veA are missing. However, these transcription
factors also display negative regulation. For instance, an increase
in the biosynthesis of aflatoxin and chratoxin has been observed
when yap1 is deleted in A. parasiticus and A. ochraceus (Yin
et al., 2013; Knox and Keller, 2015; Wang X. et al., 2015). MeaB
is another bZIP transcriptional factor which was discovered in
A. nidulans. Its function is associated in nitrogen regulation and
has a negative effect on the biosynthesis of aflatoxin in A. flavus
and bikaverin production in F. fujikuroi (Wagner et al., 2010;
Amaike et al., 2013).
Other global regulators. AreA is a highly conserved
transcriptional factor in fungi that belongs to the GATA
family and it is characterized by Cys2His2 zinc finger DNA
binding domains. Likewise, it is involved in the repression
of nitrogen metabolism when ammonium or glutamine are
present. Recently, this transcription factor and its orthologs
have been shown to influence secondary metabolism. For
instance, areA deletion strains of F. verticillioides are not able to
produce fumonisins on mature maize kernels. In Acremonium
chrysogenum, the deletion of areA resulted in the reduction
of cephalosporin because of a reduced expression of the
enzymes involved in cephalosporin biosynthesis. Additionally,
AreA is a positive regulator of the production of gibberellins,
trichothecene deoxynivalenol (DON), fusarielin H, beauvericin
and zearalenone (Li et al., 2013; Tudzynski, 2014; Knox and
Keller, 2015 and Keller, 2015). The carbon catalytic repressor
CreA also influences secondary metabolism. CreA is a Cys2His2
zinc finger transcription factor that is involved in the repression
of genes associated with the use of carbon sources other than
glucose (Knox and Keller, 2015). This transcription factor acts
by direct competition with activator proteins for specific binding
sites (5′-SYGGRG-3′) and by direct interaction with activators
(Janus et al., 2008). In P. chrysogenum CreA represses penicillin
biosynthesis and causes a reduced expression of the pcbAB gene
that encodes a NRPS involved in this pathway. Mutations in
the putative CreA binding site in the pcbAB promoter result
in enhanced enzyme expression when cells are grown in the
presence of glucose (Cepeda-García et al., 2014). In contrast,
mutations in the CreA binding sites of the ipnA promoter (pcbC
in other species) of A. nidulans revealed that in this organism
repression of penicillin biosynthesis by glucose is independent of
CreA (Knox and Keller, 2015). CreA has been implicated in the
variable metabolite profiles when fungi are grown in the presence
of different carbon sources (Yu and Keller, 2005). Recently, the
xylanase promoter binding protein (Xpp1) of Trichoderma reesei
was used as a reporter to fulfill a dual role in the regulation
of primary and secondary metabolism. Xpp1 is an activator of
primary metabolism, while its deletion boosts the production
of secondary metabolites, including sorbicillinoids (Derntl
et al., 2017b). Another Cys2His2 zinc finger transcription factor
conserved in fungi is PacC, which is involved in pH dependent
regulation. Deletion of the ortholog of this gene (BbpacC)
in Beauveria bassiana resulted in a loss of dipicolinic acid
(insecticide compound) and oxalic acid production, compounds
that reduce the pH of the medium. However, also production
of a yellow pigment was noted. When A. nidulans is grown
at alkaline pH, PacC modulates the expression of the acvA
(pcbAB) and ipnA of the penicillin BGC, while it acts negatively
on the expression of the sterigmatocystin BGC (Deepika et al.,
2016; Luo et al., 2017). In filamentous fungi, another global
regulatory element is the CCAAT-binding complex (CBC). This
complex consists of three proteins (HapB, HapC, and HapE)
that respond to redox stimuli and an additional unit HapX, a
bZIP protein that interacts with the complex for modulating
the iron levels. In A. nidulans this complex binds to CAATT
motifs, which are present in the penicillin BGC stimulating the
expression of the ipnA and aatA (penDE) genes (Bayram and
Braus, 2012; Brakhage, 2012). Whereas in F. verticillioides the
ortholog core of this complex (FvHAP2, FvHAP3, and FvHAP5)
is deleted, cells show an altered hyphal morphology, reduction of
growth, reduced pathogenesis and a deregulation of secondary
metabolism (Ridenour and Bluhm, 2014).
Specific regulator-based regulation
In addition to the global regulators, the expression of BGCs can
be also modulated by specific regulatory elements, which most of
the times are encoded by genes that are part of the same cluster
that they regulate. In some cases, such regulators also influence
the expression of other BGCs. It is estimated that about 60% of
the fungal BGCs contain a gene encoding a potential regulator
amidst the gene cluster. With PKS containing BGCs mostly
containing a regulator that belongs to the Zn2Cys6 binuclear
cluster domain family (around 90%). With NRPS containing
BGCs, the putative transcription factors are more diverse. The
Zn2Cys6 family of transcription factors contain a DNA binding
domain (DBD) that has two zinc atoms coordinated by six
cysteines. There are three sub regions: a linker, a zinc finger
and a dimerization domain. Additional to a DBD, these proteins
contain two further functional domains, the acidic region and
the regulatory domain. These transcription factors can act as
monomers, hetero- and homodimers. They recognize single
or multiple trinucleotide sequences, commonly CCG triples,
in a symmetric or asymmetrical format. The affinity of the
DBD for a given DNA stretch is also determined by the
nucleotides surrounding this triplet. The transcriptional activity
of these proteins is regulated by phosphorylation, exposing
the activation and DNA binding domains for DNA binding
(MacPherson et al., 2006; Brakhage, 2012). Some of these
regulators have been shown to control the expression of BGCs.
For instance, in F. verticillioides the disruption of FUM21 gene,
that encodes a Zn2Cys6 protein, reduces fumonisin production
as a result of a downregulation of the BGC (Brown et al.,
2007). Interestingly, fumonisin production is also regulated by
another Zn2Cys6 protein that is encoded by a gene located
outside of the fumonisin cluster (Flaherty and Woloshuk,
2004). Mlcr is another example of a positive regulator that
controls compactin production in P. citrum (Abe et al., 2002).
AflR is a Zn2Cys6 protein that regulates the biosynthesis of
aflatoxin/sterigmatocystin through binding to a palindromic
sequence (5′-TCG(N5)GCA) that is found in most of the
promoters of this BGC, albeit a second binding sequence has been
reported that is associated with the autoregulation mechanism
of the expression of AflR. The disruption of AlfR abolishes
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the production of aflatoxin/sterigmatocystin. Likewise, some
BGCs encode multiple regulatory proteins. Next to the aflR
gene in the aflatoxin cluster resides the aflS (formerly aflJ)
gene. The corresponding transcription factor binds to AflR
to enhance the transcription of early and mid-biosynthetic
genes in the aflatoxin pathway (Georgianna and Payne, 2009;
Yin and Keller, 2011). In P. chrysogenum and Trichoderma
reesei, the sorbicillin BGC is regulated by two transcriptional
factors through a coordinated action (Derntl et al., 2016, 2017a;
Guzmán-Chávez et al., 2017). Also, regulation of BGCs via
crosstalk has been observed in filamentous fungi. For instance,
the alcohol dehydrogenase promoter has been used to induce the
expression of putative pathway-specific regulatory gene (scpR)
in A. nidulans, which controls the expression of two pathway
associated NRPS genes (inpA and inpB). Surprisingly, two PKS
genes (afoE and afoG) and one transcriptional activator (afoA)
belonging to the asperfuranone BGC are also upregulated by
ScpR, allowing the production of asperfuranone (Bergmann et al.,
2010). For some regulators, no clear phenotype is observed.
For instance deletion of the chyR gene of the chrysogine BGC
in P. chrysogenum, has no effect on the expression of the
corresponding BGC (Viggiano et al., 2017).
Manipulation of regulatory elements as strategies for the
activation of BGCs
Gene deletion. It is a classical strategy that consists of the
abolishment of the expression of a certain gene by its elimination
whereupon the impact on the metabolite profile is examined
by HPLC or LC-MS. A major limitation of this approach is
that it can only be used in BGCs that are not totally silenced
under laboratory conditions. Using this strategy, it was possible
to elucidate the highly branched biosynthetic pathway for the
synthesis of roquefortine as well as the biosynthetic pathways of
sorbicillinoids and chrysogine in P. chrysogenum (García-Estrada
et al., 2011; Ali et al., 2013; Ries et al., 2013; Deepika et al., 2016;
Guzmán-Chávez et al., 2017; Viggiano et al., 2017). Likewise,
this approach can be used to remove transcriptional repressor
genes, as in the case of TetR-like pathway-specific repressor
proteins, whose deletion induced the production of gaburedins
in Streptomyces venezuelae (Rutledge and Challis, 2015). Global
regulators, such as LaeA have also been targeted using this
strategy (Chiang et al., 2009).
Promoter replacement. Another method concerns the
replacement of the endogenous promoter of the gene(s) in
a BGC by a strong constitutive or inducible promoter. For
instance in A. nidulans replacement of the native promotor of the
scpR gene (secondary metabolism cross-pathway regulator) for
the inducible promoter of alcohol dehydrogenase AlcA induced
the expression of a silent cluster that contained two NRPS genes
(inpA and inpB) and scpR itself. Additionally, it also led to
the expression of the asperfuranone BGC, which is normally
silent (Bergmann et al., 2010; Yin and Keller, 2011; Lim et al.,
2012). Recently in P. chrysogenum a promising promoter toolbox
for bioengineering purposes was developed. This included the
analysis of four constitutive promoters from P. chrysogenum and
six from A. niger, which were evaluated using a reporter system
and assorted by promoter strength (Polli et al., 2016).
Overexpression of a specific or global regulator. This approach is
one of the most used strategies to turn on cryptic BGCs, since a
change in expression level of a regulator may boost the expression
of a whole cluster. Usually, this strategy is applied in combination
with the promoter replacement approach. Using this strategy,
i.e., overexpression of the transcription activator ApdR under
control of the alcohol dehydrogenase promoter alcAp, it has been
possible to induce the expression of a hybrid PKS-NRPS BGC in
A. nidulans. This resulted in the production of aspyridones A and
B (Bergmann et al., 2007). Similarly when the global regulator
FfSge, which is associated with vegetative growth of F. fujikuroi,
is overexpressed, some BGCs are forced to express under these
unfavorable conditions (low nitrogen concentrations) leading to
the identification of the corresponding products (Michielse et al.,
2015).
Chromatin-Mediated Regulation
In fungal cells, chromosomal DNA is wrapped in a complex
of DNA, histone proteins and RNA called chromatin. This
chromatin structure consists of a basic unit called nucleosome,
which consists of superhelical DNA (147 base pairs) that binds
an octamer of four different core histone proteins (two each
of H2A, H2B, H3, and H4) in 1.75 turns. It has been shown
that modifications of the chromatin structure (boosts or alters)
changes gene expression, amongst other genes involved in the
biosynthesis of secondary metabolites. Structurally, chromatin
represents an obstacle that complicates access of DNA-binding
factors to their corresponding binding regions. According to the
compaction level, chromatin can be in a dense (heterochromatin)
or relaxed (euchromatin) state. These compaction levels are
regulated by post-translational modification of the histone
proteins by acetylation, methylation, ubiquitination, ethylation,
propylation, butylation, and phosphorylation events. Regions
that display low transcriptional activity have been associated with
the heterochromatic conformation. In contrast, the euchromatic
conformation is present in regions with abundant coding
sequences and is usually highly active during transcription.
Such regions are also linked with hyper-acetylated nucleosomal
histones. Likewise, it has been reported that methylation of H3K9,
H3K27, and H4K20 are typical markers of the heterochromatin,
while in euchromatin methylation occurs at H3K4 (Brosch et al.,
2008; Strauss and Reyes-Dominguez, 2011; Gacek and Strauss,
2012; Spraker and Keller, 2014; Rutledge and Challis, 2015).
Histone methylation, acetylation, and sumoylation
As mentioned above, LaeA influences secondary metabolite
production through chromatin modification. The methylation
state of H3K9 has been correlated with the heterochromatin
protein A (HepA), since this protein needs the di- and tri-
methylation of H3K9 for binding to chromatin and to form
heterochromatin. Deletion of LaeA allows the unobstructed
binding of HepA to the AlfR promoter, thereby affecting the
expression of the sterigmatocystin pathway. The deletion of the
methyltransferase encoding clrD and ezhB genes in Epichloe
festucae, that act on H3K9 and H3K27, respectively (in axenic
culture), results in the activation of the ergot alkaloids and
lolitrem BGCs. These compounds are necessary to establish a
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symbiotic association with the plant Lolium perenne. Compass
(complex of proteins associated with Set1) which methylates
H3K4 in yeast, also impacts secondary metabolism in filamentous
fungi. The deletion of one of its components (cclA) in A. nidulans
allowed the activation of a cryptic BGC and the production
of emodin (Palmer and Keller, 2010; Gacek and Strauss, 2012;
Chujo and Scott, 2014; Netzker et al., 2015; Deepika et al., 2016).
Likewise, in F. fujikuroi and F. graminearum, the deletion of
cclA caused the overproduction of secondary metabolites derived
from BGCs close to the telomeres, but this seems to relate to a
H3K4 methylation independent mechanism (Studt et al., 2017).
Other types of histone modification may alter the chromatin
landscape, such as acetylation which is a reversible process
governed by two antagonist enzymes: histone acetyltransferases
(HATs) and deacetylases (HDACs). Active transcription is
usually associated with histone acetylation, although recently the
deacetylation of histones has been shown to cause activation of
genes (Brosch et al., 2008). Usually, histones are acetylated by
several complexes with acyltransferase activity, such as Saga/Ada
and NuA4. In A. nidulans a chromatin immunoprecipitation
(ChIP) analysis revealed that GcnE and AdaB, the catalytic
subunits of the complex Saga/Ada, are needed for acetylation of
histone H3 (Deepika et al., 2016). Indeed, the interaction between
A. nidulans and Streptomyces rapamycinicus can be linked to a
GcnE dependent increase in the acetylation of H3K14 that shields
the promoters of the orsellinic acid BGC. The Saga/Ada complex
is a key player in the induction of the penicillin, terrequinone
and sterigmatocystin BGCs (Nutzmann et al., 2011; Brakhage,
2012). In contrast, deletion of hdaA (encoding a HDAC) in
A. nidulans resulted in major changes in the metabolite profile
(Rutledge and Challis, 2015). HdaA is a class 2 histone deacetylase
involved in the regulation of BGCs that are located near the
telomeres, such as the penicillin and sterigmatocystin clusters
in A. nidulans. Indeed, deletion of the hdaA gene results in
the increased and early gene expression of these two BGCs,
and the production of the corresponding secondary metabolites.
In A. fumigatus, the hdaA gene is involved in growth and
production of secondary metabolites, and the deletion of this
gene increases the production of many secondary metabolites
while it causes a reduction of gliotoxin production. In contrast,
HdaA overexpression shows the opposite effect (Shwab et al.,
2007; Lee et al., 2009). In P. chrysogenum was demonstrated that
HdaA (histone deacetylase) mediates the transcriptional crosstalk
among sorbicillinoids biosynthesis and other BGCs, since a new
compound as detected only under conditions of sorbicillinoids
production (Guzmán-Chávez et al., 2018).
Histone deacetylases are ubiquitously distributed in
filamentous fungi, and therefore HDAC inhibitors can be used
to improve the synthesis of NPs by epigenome manipulation
(Shwab et al., 2007; Lee et al., 2009). For instance, the metabolite
profile of Cladosporium cladosporioides and A. niger underwent
a significant change when these strains were exposed to
suberoylanilide hydroxamic acid (SAHA), a HDAC inhibitor,
allowing the detection of two new compounds, cladochrome
and nygerone A, respectively (Rutledge and Challis, 2015).
An exploratory analysis performed in 12 fungi treated with
different types of DNA methyltransferase and histone deacetylase
inhibitors, revealed the production of new secondary metabolites
but also the elevated amounts of known compounds (Williams
et al., 2008). In this respect, the chromatin state can directly
influence the binding of transcription factors, and thereby
modulate expression (Palmer and Keller, 2010; Macheleidt et al.,
2016). It has been hypothesized that histone sumoylation may
modulate secondary metabolite production. This process is
mediated by a small protein termed SUMO (small ubiquitin-like
modifier) that shares structural similarity to the ubiquitin
protein. In A. nidulans, deletion of the sumO gene enhanced
the production of asperthecin, whereas synthesis of austinol,
dehydroaustinol, and sterigmatocystin was reduced. Although
the molecular mechanism still needs to be elucidated, it is thought
that sumoylation acts at several levels, such as on epigenetic
regulators (COMPASS, Clr4, SAGA/ADA and HDACs) or at
the level of transcriptional regulators (Brakhage and Schroeckh,
2011; Spraker and Keller, 2014; Wu and Yu, 2015).
Modification of the chromatin landscape to activate BGCs
Many fungal BGCs are located in distal regions of the
chromosomes. In these heterochromatin rich regions,
transcription of the BGCs can be activated by epigenetic
regulation. Therefore, the encoding genes of proteins that
influence histone modification are prime targets, although
these modifications can also be achieved by chemical treatment
(Williams et al., 2008; Brakhage, 2012). A recent study in
P. chrysogenum showed that the expression of a set of PKS and
NRPS encoding genes is induced when an ortholog of a class
2 histone deacetylase (HdaA) is deleted. This allowed for the
overproduction of sorbicillinoids, the reduction of chrysogine
related metabolites and the detection of a new compound whose
origin still unknown (Guzmán-Chávez et al., 2018).
Other Targets for Regulation
Secondary metabolites produced by fungi can be toxic to
the producer organisms, and often fungi are equipped with
detoxification mechanisms. One of these mechanisms is toxin
excretion by transporters, which are membrane proteins whose
genes often localize to the BGCs. Transporters may belong to
different protein families but the major facilitator superfamily
(MFS) and ABC superfamily are most commonly encoded by
BGCs (Keller, 2015). Since biosynthesis of secondary metabolites
may take place in different cell compartments, also intracellular
transport may be evident (Kistler and Broz, 2015). Despite their
assumed biological importance, the deletion of transporter genes
from the BGCs often does not impact secondary metabolite
production. For instance, deletion of the A. parasiticus aflT gene,
that encodes a MFS transporter, does not result in reduced
aflatoxin excretion, despite the fact that aflT belongs to the
aflatoxin BGC and its expression is regulated by a specific
transcription factor, AflR, of the pathway. Probably, this protein
is redundant, and other transporters may participate in excretion,
detoxification or self-defense. In A. fumigatus, GliA facilitates
the excretion of gliotoxin. Similarly, the tri12 gene contained
in the trichothecene BGC encodes for a membrane protein
required for the biosynthesis of trichothecene and virulence of
F. graminearum on wheat crops (Chang et al., 2004; Menke
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et al., 2012; Wang D.N. et al., 2014; Keller, 2015). Often,
however, the deletion of the transporter gene in BGCs has
no effect on production. Possibly, these metabolites are also
recognized by other promiscuous transporters, or transporters
that are not part of the BGC (Keller, 2015). For example,
ZRA1 of Gibberella zae, whose gene is not localized to the
zearalenona BGC, impacts zearalenone production. However, the
expression of the zra1 gene is regulated by the transcriptional
factor ZEB2, whose gene localizes to the corresponding BGC
(Lee et al., 2011). Also, the penicillin BGC of P. chrysogenum
lacks a transporter gene whereas export of penicillin occurs
against the concentration gradient, probably through the activity
of multiple transporter proteins (van den Berg et al., 2008; Kistler
and Broz, 2015). Furthermore, compartmentalization of the
biosynthesis of penicillin is well documented requiring transport
of penicillin precursors across the membrane of intracellular
organelles (Weber et al., 2012a,b).
Other Genetic Engineering Strategies for the
Activation of BGCs
Several approaches have been used to activate the expression
of cryptic BGCs in a targeted manner. Usually, this is achieved
by manipulation of pathway-specific regulatory genes, or by
replacing endogenous promoters for inducible systems or strong
promoters (Rutledge and Challis, 2015). The various approaches
are summarized in Figure 7.
Manipulating biosynthetic pathways by genome editing
Due to the increasing number of sequenced filamentous fungi,
it is necessary to make use of efficient genome editing tools
to explore new potential sources of secondary metabolites. For
many years, the unique strategy available for the genome edition
of P. chrysogenum was based on the use of ku70/80 disrupted
strains to improve the homologous recombination instead of the
Non-Homologous End Joining (NHEJ) pathway (Weber et al.,
2012a). This strategy allowed for the generation P. chrysogenum
strains with high copy numbers of the penicillin cluster, the
identification of a biosynthetic branch of the roquefortine
cluster and the reactivation of the sorbicillinoid gene cluster
(Nijland et al., 2010; García-Estrada et al., 2011; Ali et al.,
2013; Ries et al., 2013; Salo et al., 2016; Guzmán-Chávez et al.,
2017). Recently, a CRISPR/Cas9 based system was developed
for genome modifications in P. chrysogenum (Pohl et al., 2016,
2018). This study demonstrated that the deletion of full gene
clusters is feasible with minimal cloning efforts, which opens
the possibilities to engineer new synthetic pathways and the
re-factoring P. chrysogenum as platform organism.
Ribosome engineering
This approach has been applied for activating silent or poorly
expressed BGCs (Ochi and Hosaka, 2013). Basically, this concept
is derived from the activation of the actinorhodin BGC in
S. lividans due to a point mutation in the rpsL gene, which
encodes for the ribosomal S12 protein (Shima et al., 1996).
Another successful examples in the BGCs activation have been
reported by modifying the transcription and translation pathways
via targeting different ribosomal proteins, RNA polymerases
(RNAP) and translation factors (Ochi and Hosaka, 2013). In
P. purpurogenum G59, a marine derived strain, the insertion of
gentamicin resistance after treatment with high concentrations of
this antibiotic, altered ribosomal functions of this fungus which
allowed for the activation of dormant secondary metabolite gene
clusters (Chai et al., 2012).
Heterologous expression and refactoring
Due to the broad range of molecular tools available to
express heterologous pathways in yeast, several attempts have
been undertaken to express NRPS and PKS genes with the
remainder of the pathway in yeast (Rutledge and Challis, 2015).
A recent study demonstrated that the baker’s yeast Saccharomyces
cerevisiae can be used as a platform to produce and secrete
penicillin when the biosynthetic genes are expressed in this
organism (Awan et al., 2016). Although the first step was
performed when the acetyl-CoA:isopenicillin N acyltransferase
(IAT), which catalyzes the last step in the penicillin biosynthesis
was amplified from the P. chrysogenum penDE gene and
expressed in Hansenula polymorpha (Lutz et al., 2005). However,
most of the times the main obstacle is the large size (>40 kbp)
of the DNA fragment that needs to be cloned, the effective
activation/maturation of the expressed enzymes, and the toxicity
of the produced compounds (Rutledge and Challis, 2015).
Alternatively, fungi may be used as platform organism, as it
was for instance demonstrated with the reconstruction of the
citrinin gene cluster of Monascus purpurea in A. oryzae (Spraker
and Keller, 2014). Likewise, the in vivo assembly of genetic
elements has been successfully applied in P. chrysogenum through
the overlapping of bi-partite fragments that reconstituted a
functional amdS gene (marker), which eventually is integrated in
the genome of this fungus proving the uncharacterized potential
of P. chrysogenum as heterologous host (Polli et al., 2016). The
potential of this approach follows a recent study employing
A. nidulans as a host for the plasmid based expression of a diverse
range of BGCs from other filamentous fungi (Clevenger et al.,
2017).
The introduction of revolutionary new genetic tools, such as
CRISPR/Cas9 offers more effective solutions to express specific
BGCs. Such methods can contribute to product identification but
also to the production of unique compounds by introduction
of specific tailoring enzymes. These are the main strategies
that are used for the activation of silent BGCs or for the
modification/redirection of known biosynthetic pathways in
order to increase NP diversification (Smanski et al., 2016).
Specifically, this involves the expression of pathways from a
plasmid in a suitable production host and a screen for product
formation.
CONCLUDING REMARKS
For many years P. chrysogenum has been used as one of the main
industrial strains to produce penicillins (β-lactams). Its genome
sequence revealed an unexplored potential of P. chrysogenum
as a source of NPs (van den Berg et al., 2008). Despite
the development of bioinformatics tools for genome mining
of BGCs to identify novel molecules (Blin et al., 2017), the
experimental validation of product structure and identity is still
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FIGURE 7 | Regulatory targets and strategies to engineer P. chrysogenum and other filamentous fungi for secondary metabolite formation. For details see the text.
necessary. However, most of the secondary metabolite associated
genes in P. chrysogenum are silent or poorly expressed. Given
the urgent need for new molecules based on novel chemical
scaffolds for the use in the medical and biotechnological fields
(e.g., antibiotics, anti-cancer agents, antivirals, nutraceuticals,
pigments, surfactants and many more), the use of organisms
that have been genetically domesticated offers a promising target
solution for NP discovery due to the availability of molecular
tools for their genetic modification. Here, we have summarized
the main approaches that have been applied for P. chrysogenum
and other filamentous fungi to bioengineer secondary metabolite
BGC pathways which have led to a greater understanding of
the main obstacles to be overcome to use this fungus as a
generic cell factory. We discussed the main characteristics of
the building enzymes (PKS and NRPS) in filamentous fungi.
Despite the apparent modular organization, the complexity of
these mega enzymes and the inherent interactions between the
various domains within their structures has not allowed a straight
forward approach for the PKS/NRPS engineering (Thirlway
et al., 2012; Zhang et al., 2013; Weissman, 2016). However, the
combinatorial swapping strategy of structural elements such as
recognition regions has increased the perspectives for designing
de novo biosynthetic pathways. Further research needs to be
focused around PKS/NRPS engineering in filamentous fungi to
facilitate the rational design of biosynthetic enzymes to produce
another generation of novel compounds. To mine the secondary
metabolome of filamentous fungi, general methods such as
manipulating cultivation conditions have been used that can also
be implemented as a high-throughput strategy. Another avenue
is interfering with the genetic regulatory systems, either through
the manipulation of specific or global regulators. This strategy
also revealed crosstalk between certain BGCs and an important
role of chromatin remodeling in BGC expression. Because of
its pleiotropic effect that leads to the activation or silencing
of biosynthetic pathways, chromatin remodeling might be used
as a more general strategy to explore the production of new
metabolites in filamentous fungi (Guzmán-Chávez et al., 2018).
A further major advance is the development of genome-
editing tools that allow for efficient genetic engineering
of complex fungal cell factories (Jakoèiunas et al., 2016).
In P. chrysogenum, improved methods for homologous
recombination and CRISPR/Cas9 as genome editing tool
now facilitates more advanced engineering of this fungus
(Pohl et al., 2016, 2018). This is further stimulated by
the development of a synthetic biology toolbox using
promoters and terminators as building blocks and more
complex regulatory devices to control the expression of
genes. Importantly, the in vivo assembly of genetic elements
in P. chrysogenum offers a promising tool to build entire
pathways from scratch with reducing cloning efforts at
minimal costs (Polli et al., 2016). In particular the low
cost of DNA synthesis will allow rapid progress using such
approaches as exemplified by a study using A. nidulans as
a host where a diverse set of BGCs was expressed from an
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extra-chromosomal vector, the AMA plasmid (Clevenger et al.,
2017). A further challenge is the generation of a platform strain
in which endogenous BGCs have been removed to allow for more
optimal carbon and nitrogen flow toward the production of the
compounds of interest. Herein, the CRISPR/Cas9 based methods
are instrumental (Pohl et al., 2016, 2018). Such a Penicillium
platform might be used as a heterologous host to express a vast
arsenal of BGCs from others filamentous fungi and represents
a good alternative to yeast as expression host, an organism that
does not naturally produce NRP and PK. The use of a such
industrial strains to rapidly achieve the high level production of
a novel metabolite has proven to be successful for pravastatin
production (McLean et al., 2015) but a further step is to make
use of secondary metabolite deficient industrial strains.
Despite the progress in genetic engineering and
bioinformatics tools to identify BGCs, the main bottleneck to
identify potentially interesting compounds has not yet been
solved. Bioinformatic tools perform poorly in the prediction of
the structures formed, and therefore future discovery programs
will mostly dependent on high throughput methods to express
foreign pathways and then use advanced metabolomics to
identify the novel products. Since such approaches depend on
high throughput, further efforts are needed to implement high
throughput cloning methods to P. chrysogenum which will enable
further studies to harness the enormous untapped source for NPs
hidden in fungal (meta-)genomes.
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